跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
TAKHZYRO 300 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
TAKHZYRO 300 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Takeda Pharmaceuticals International Ag Ireland Branch
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 9, 2020
Approval ID
fbd3c1072a1d25dc
Company
Takeda Pharmaceuticals International Ag Ireland Branch
Type
Standard
Approval Details
Approval Id
fbd3c1072a1d25dc
Drug Cima Aemps Name
TAKHZYRO 300 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number
1181340004
Holder Company Name
Takeda Pharmaceuticals International Ag Ireland Branch
Marketing Company Name
Takeda Farmaceutica Espana S.A.
Holder Company Detail Path
/organization/takeda-pharmaceuticals-international-ag-ireland-branch
Authorization Date
2020-09-09
Dosage Form
SOLUCIÓN INYECTABLE
Dose
300 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Takeda Pharmaceuticals International Ag Ireland Branch
Company Detail Path
/organization/takeda-pharmaceuticals-international-ag-ireland-branch
Company Information
Pharmaceutical Company Name
TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE RAIMUNDO FERNANDEZ VILLAVERDE, 63 - 16
Active Ingredients
LANADELUMAB
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 9, 2020
Approval ID
fbd3c1072a1d25dc
Type
Standard
Back to CIMA-AEMPS Approvals
TAKHZYRO 300 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details